Mesoblast | Umsatzkosten



Cost Of Sales Veränderung Datum
Avita Medical AUD 2.28M 170K 2024-12
Clinuvel Pharmaceuticals AUD 1.93M 4.97M 2024-06
Cochlear AUD 269.9M 300K 2024-06
CSL USD 3.41B 315M 2024-06
Pacific Edge 280K 0 2024-03
Paradigm Biopharmaceuticals AUD 8.99K 8.99K 2024-06
PYC Therapeutics AUD 3.1M 2.8M 2020-12
Ramsay Health Care AUD 2.23B 6.3M 2024-12
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Starpharma Holdings AUD 2.61M 2.41M 2024-06
Telix Pharmaceuticals AUD 148.66M 10.4M 2024-12



Mesoblast Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.